Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial-Reference-Cited by-同舟云学术

Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial

Published:2016-10 Issue:10056 Volume:388 Page:2115-2127
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Bleecker Eugene R,FitzGerald J Mark,Chanez Pascal,Papi Alberto,Weinstein Steven F,Barker Peter,Sproule Stephanie,Gilmartin Geoffrey,Aurivillius Magnus,Werkström Viktoria,Goldman Mitchell

Publisher

Elsevier BV

Subject

General Medicine

Reference28 articles.

1. Global asthma prevalence in adults: findings from the cross-sectional world health survey;To;BMC Public Health,2012

2. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma;Chung;Eur Respir J,2014

3. Asthma: still a promising future?;Chanez;Eur Respir Rev,2014

4. Risk factors for death in patients with severe asthma;Fernandes;J Bras Pneumol,2014

5. Direct health care costs associated with asthma in British Columbia;Sadatsafavi;Can Respir J,2010

Cited by 1093 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a novel humanized anti-TSLP monoclonal antibody, QX008N, and exploration of combination therapy of anti-TSLP antibody and anti-IL-4R antibody;International Immunopharmacology;2024-12

2. Effect of benralizumab on inflammation in skin after intradermal allergen challenge in patients with moderate-to-severe atopic dermatitis;Journal of Allergy and Clinical Immunology: Global;2024-11

3. Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype;New England Journal of Medicine;2024-09-09

4. Current Practices in Pediatric Asthma Care;Clinics in Chest Medicine;2024-09

5. ZFP36 family expression is suppressed by Th2 cells in asthma, leading to enhanced synthesis of inflammatory cytokines and cell surface molecules;Cellular Immunology;2024-09